Recurrent VTE in Cancer Still Problematic - MedPage Today

Recurrent VTE in Cancer Still Problematic  MedPage Today

Patients with cancer-associated pulmonary embolism (PE) had a significant risk of recurrent venous thromboembolism (VTE) at 12 months, despite ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more